The role of size in PEGylated liposomal doxorubicin biodistribution and anti‐tumour activity

The role of size in PEGylated liposomal doxorubicin biodistribution and anti‐tumour activity

Abstract The size of nanoliposome‐encapsulated drugs significantly affects their therapeutic efficacy, biodistribution, targeting ability, and toxicity profile for the cancer treatment. In the present study, the biodistribution and anti‐tumoral activity of PEGylated liposomal Doxorubicin (PLD) formu...

Full description

Saved in:

Bibliographic Details
Main Authors:	Saba Dadpour, Amin Mehrabian, Mahdieh Arabsalmani, Elaheh Mirhadi, Anis Askarizadeh, Mohammad Mashreghi, Mahmoud Reza Jaafari
Format:	Article
Language:	English
Published:	Wiley 2022-09-01
Series:	IET Nanobiotechnology
Subjects:	Biodistribution Cancer EPR effect Nanoparticle size PEGylated liposomal doxorubicin Therapeutic efficacy
Online Access:	https://doi.org/10.1049/nbt2.12094
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Characterization and in vitro anticancer study of PEGylated liposome dually loaded with ferulic acid and doxorubicin
by: Andang Miatmoko, et al.
Published: (2025-01-01)

The comparison of biodistribution of glutathione PEGylated nanoliposomal doxorubicin formulations prepared by pre‐insertion and post‐insertion methods for brain delivery in normal mice
by: Amin Mehrabian, et al.
Published: (2023-04-01)

Biodistribution of intravenously delivered PEGylated carbon nanotubes to the rat brain cortex
by: Gisele Eva Bruch, et al.
Published: (2025-01-01)

A multicenter, randomized, open label, two formulation, crossover bioequivalence trial of doxorubicin hydrochloride liposomal injection in Chinese patients with metastatic breast cancer
by: Jingshu Wang, et al.
Published: (2025-01-01)

Synthesis and Characterization of PEGylated Liposomes and Nanostructured Lipid Carriers with Entrapped Bioactive Triterpenoids: Comparative Fingerprints and Quantification by UHPLC-QTOF-ESI<sup>+</sup>-MS, ATR-FTIR Spectroscopy, and HPLC-DAD
by: Carmen Socaciu, et al.
Published: (2024-12-01)

Doxorubicin-loaded PEGylated liposome modified with ANGPT2-specific peptide for integrative glioma-targeted imaging and therapy
by: Hongyan Li, et al.
Published: (2025-02-01)

Electrostatic properties of human germlines and biodistribution of small biologics
by: Leticia Maria De Souza Cordeiro, et al.
Published: (2024-12-01)

Iron(III)–Quercetin Complex: In Vivo Acute Toxicity and Biodistribution of Novel MRI Agent
by: Innuan P, et al.
Published: (2025-01-01)

Enhanced effect of the immunosuppressive soluble HLA-G2 homodimer by site-specific PEGylation
by: Chisato Yamada, et al.
Published: (2025-01-01)

<i>In vitro</i> and <i>in vivo</i> tropism and biodistribution of recombinant simian adenovirus type 25
by: Irina V. Vavilova, et al.
Published: (2024-11-01)

Is Combined Bulevirtide and Pegylated Interferon Therapy for Chronic Hepatitis D Superior over Bulevirtide Monotherapy?
by: V. E. Syutkin, et al.
Published: (2020-09-01)

Potentiation of Doxorubicin Cytotoxicity Utilizing Clarithromycin Loaded-PEGylated Liposomes
by: Islam Alfreahat MS, et al.
Published: (2025-01-01)

Investigation of the efficacy of tyrosol on doxorubicin-induced acute cardiotoxicity in rats
by: Mustafa Cellat, et al.
Published: (2022-09-01)

Effect of pimobendan on cytokine levels in doxorubicin-induced cardiotoxicity
by: Burak Dik, et al.

Severe Lipoatrophy in a Growth Hormone Deficient Toddler Girl Treated with a Non-Pegylated Long-Acting Growth Hormone
by: Atilla Büyükgebiz, et al.
Published: (2025-01-01)

Streptomyces-derived nano-doxorubicin: Clinical status and patents granted
by: Kaur Prabhjot, et al.
Published: (2024-01-01)

Analysis of doxorubicin and fullerenol in rat serum by micellar electrokinetic capillary chromatography
by: Injac Rade, et al.
Published: (2024-09-01)

Histopathological evaluation of the effects of thymoquinone and resveratrol on the liver in rats administered doxorubicin
by: Mehmet Burak Ates, et al.
Published: (2022-09-01)

Determination of protective effectiveness of nerium oleander distillation in doxorubicin-induced organ damages
by: Burak Dik, et al.

Pegylated NIR Fluorophore-Conjugated OBHSA Prodrug for ERα-Targeted Theranostics with Enhanced Imaging and Long-Term Retention
by: Xiaohua Wang, et al.
Published: (2025-01-01)

Apelinergic System Affects Electrocardiographic Abnormalities Induced by Doxorubicin
by: Kasper Buczma, et al.
Published: (2025-01-01)

Survival Analysis of Ovarian Carcinosarcomas Depending on Platinum or Doxorubicin Based Adjuvant Chemotherapy
by: İlker Selçuk, et al.
Published: (2015-04-01)

Investigation of Doxorubicin Efficiency in Some Hematological Parameters in Women with Breast Cancer in Iraq
by: Hanan B. Saadon
Published: (2024-12-01)

Cannabidiol Ameliorates Doxorubicin-Induced Myocardial Injury via Activating Hippo Pathway
by: Dong T, et al.
Published: (2025-01-01)

Enhancing Anticancer Potential: Investigating the Synergistic Impact of Doxorubicin and Curcumin on HeLa and Vero Cells in Vitro
by: Windy Aristiani, et al.
Published: (2024-04-01)

The potential synergistic effect of combining doxorubicin with vorinostat in urothelial carcinoma therapy
by: Cheng-Huang Shen, et al.
Published: (2025-01-01)

Liposomal Formulation of Hydroxychloroquine Can Inhibit Autophagy In Vivo
by: Wieslawa H. Dragowska, et al.
Published: (2024-12-01)

Effect of selected catechins on doxorubicin antiproliferative efficacy and hepatotoxicity in vitro
by: Rudolfová Petra, et al.
Published: (2014-06-01)

Application of a liposomal subunit vaccine in chickens for reduction of Campylobacter gut colonisation
by: Łasica Anna, et al.
Published: (2024-11-01)

Peiminine Enhances Doxorubicin Cytotoxicity and Downregulates hsa-miR-106a-5p and hsa -miR-181a-5p in Human Gastric Adenocarcinoma Cells
by: Shirin Hedayati, et al.
Published: (2024-12-01)

Are We Ready to Measure Skin Permeation of Modern Antiaging GHK–Cu Tripeptide Encapsulated in Liposomes?
by: Karolina Ogórek, et al.
Published: (2025-01-01)

Doxorubicin-Conjugated Nanoparticles for Potential Use as Drug Delivery Systems
by: Alua Imantay, et al.
Published: (2025-01-01)

Anionic liposomes prepared without organic solvents for effective siRNA delivery
by: Xiu Han, et al.
Published: (2023-05-01)

Enhancing in Vitro anti-metastatic efficacy and deep penetration into tumor spheroid of docetaxel-loaded liposomes via size optimization for prostate cancer treatment
by: Saksorn Klibaim, et al.
Published: (2025-03-01)

Astaxanthin mitigates doxorubicin-induced cardiotoxicity via inhibiting ferroptosis and autophagy: a study based on bioinformatic analysis and in vivo/vitro experiments
by: Bowen Yin, et al.
Published: (2025-01-01)

Preparation, Modification, Characterization and Antioxidant Activities of Apigenin Liposomes
by: Siyu DAI, et al.
Published: (2025-01-01)

MEKANISME KO-KEMOTERAPI EKSTRAK ROSELLA (Hibiscus sabdariffa. L) DENGAN DOXORUBICIN PADA SEL KANKER SERVIKS (HeLa) SECARA IN VITRO
by: Intan Daud, et al.
Published: (2024-11-01)

Thirty years from FDA approval of pegylated liposomal doxorubicin (Doxil/Caelyx): an updated analysis and future perspective
by: Alberto A Gabizon, et al.
Published: (2025-01-01)

Effectiveness of a Novel Liposomal Methylglyoxal–Tobramycin Formulation in Reducing Biofilm Formation and Bacterial Adhesion
by: Wed Alluhaim, et al.
Published: (2024-12-01)

Liposome-like encapsulation of fish oil-based self-nano emulsifying formulation for improved bioavailability
by: Iqbal Ahmad, et al.
Published: (2025-06-01)